13D Filing: Scopia Capital and Conmed Corp (CNMD)

Page 2 of 9 – SEC Filing

Schedule 13D
CUSIP No. 207410101
  (1)
Name of Reporting Persons:
Scopia Capital Management LP
  (2)
Check the Appropriate Box if a Member of a Group (See Instructions):
(a)  ☐        (b)  ☐
  (3)
SEC Use Only:
  (4)
Source of Funds (See Instructions):
AF
  (5)
Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e):  ☐
  (6)
Citizenship or Place of Organization:
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
  (7)
Sole Voting Power
0
  (8)
Shared Voting Power
2,489,661
  (9)
Sole Dispositive Power
0
(10)
Shared Dispositive Power
2,489,661
(11)
Aggregate Amount Beneficially Owned by Each Reporting Person:
2,489,661
(12)
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions):  ☐
(13)
Percent of Class Represented by Amount in Row (11):
8.9%*
(14)
Type of Reporting Person (See Instructions):
PN, IA
*
Based on 27,933,864 shares of Common Stock of CONMED Corporation (the “Issuer”) outstanding as of October 27, 2017, as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission (“SEC”) on November 2, 2017.
Follow Conmed Corp (NASDAQ:CNMD)